Novel metabolic and epigenetic targets for the treatment of T-Cell Acute Lymphoblastic Leukemia
Date: Monday, 06 17, 2019; Speaker: Dr. Daniel Herranz Benito, Assistant Professor of Pharmacology, Rutgers Cancer Institute of New Jersey; Building: Building 37; 6041/6107 (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - June 12, 2019 Category: American Health Source Type: events
Acute Leukemia Forum 2018
12 –13 April 2018, Newport Beach, United States (Source: Scientific and Medical Events on Global Events List)
Source: Scientific and Medical Events on Global Events List - March 23, 2018 Category: Science Source Type: events
Acute and Chronic Leukemias 2017
6 –7 October 2017, Las Vegas, United States (Source: Scientific and Medical Events on Global Events List)
Source: Scientific and Medical Events on Global Events List - September 29, 2017 Category: Science Source Type: events
A Potent Glycomimetic Antagonist (GMI-1271) of E-selectin in Phase 2 Clinical Trials for the Treatment of Acute Myelogenous Leukemia
Date: Tuesday, 07 11, 2017; Speaker: Dr. John L. Magnani, Chief Science Officer and Senior V.P., GlycoMimetics, Inc.; Building 50; Room 1227/1233 (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - July 10, 2017 Category: American Health Source Type: events
Individualizing Therapy for Patients with Acute Myeloid Leukemia (AML)
Date: Tuesday, 06 13, 2017; Speaker: Courtney DiNardo, MD, MSCE, Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center; 10; 6S233 (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - June 8, 2017 Category: American Health Source Type: events
CC Grand Rounds: 1) Developing Multifaceted Cancer Trials: Integrating Laboratory and Clinical Research and 2) Beyond CD19: What is Next for CAR T Cell Therapy in Acute Lymphoblastic Leukemia (ALL)
Date: Wednesday, 03 29, 2017; Speaker: Mark B. Gilbert, MD, Senior Investigator and Chief, Neuro-Oncology Branch, , NCI; Terry J. Fry, MD, Investigator, Pediatric Oncology Branch and Head, Hematologic Malignancies , Section, NCI; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - February 27, 2017 Category: American Health Source Type: events
Fast cars for childhood acute lymphoblastic leukemia: the promise and potential pitfalls
Date: Thursday, 03 17, 2016; Speaker: Daniel (Trey) W. Lee, MD, Assistant Clinical Investigator, St. Baldrick's Scholar , NIH, NCI, POB; Building: Building 10 (Clinical Center); 2-3750; CME Credit (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - March 17, 2016 Category: American Health Source Type: events
Measuring residual disease in Acute Myeloid Leukemia
Date: Wednesday, 11 04, 2015; Speaker: Chris Hourigan, MD DPhil FACP, Chief, Myeloid Malignancies Section, Hematology Branch, National Heart, Lung and Blood Institute; Building 10 CRC; Room 2E-3330 (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - October 30, 2015 Category: American Health Source Type: events
CC Grand Rounds (1) Measurable Residual Disease in Acute Myeloid Leukemia (2) Rare Disorders Informing Cancer Biology: Lessons Learned From Dyskeratosis Congenita
Date: Wednesday, 12 03, 2014; Speaker: Christopher Hourigan, MD, DPhil, Chief, Myeloid Malignancies Section, Hematology Branch, NHLBI; Sharon A. Savage, MD, Senior Investigator and Chief, Clinical Genetics Branch , Division of Cancer Epidemiology and Genetics, NCI; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - November 18, 2014 Category: American Health Source Type: events
